Document is current

Article History

Accepted: 29 September 2025

First Online: 29 October 2025

Declarations

:

: G.R. reports receiving research contracts from Amolyt, Pfizer, Recordati, and Novo Nordisk, all of which were paid to his institution (Hospices Civils de Lyon), with no personal remuneration. G.R. is also a principal investigator in clinical trials sponsored by Ascendis, Recordati, and Pfizer. T.B. has received research contracts from Pfizer and Novo Nordisk. T.B. has served as a consultant for Pfizer, Recordati, and Novo Nordisk, and has acted as a clinical trial investigator for Crinetics, Debiopharm, and Recordati. S.E. has received congress support and hospitality from Pfizer SAS and has participated in non-remunerated scientific collaborations. P.C. has received unrestricted research and educational grants from Ipsen, Recordati, Advanz, and Pfizer in his capacity as Head of the Department of Endocrinology and Reproductive Diseases, Assistance Publique–Hôpitaux de Paris, Université Paris-Saclay. P.C. has served as principal or coordinating investigator in clinical trials sponsored by Chiasma, Recordati, Pfizer, Crinetics, and Debiopharm. P.C. is a member of advisory boards for Pfizer, Recordati, and Amolyt/Alexion, and has given lectures for Ipsen, Recordati, and Pfizer. All fees and honoraria were paid to his institution or affiliated research association. D.D. has received congress invitations and speaker fees from Pfizer related to the topic of the current work. J.C. has received congress support and other benefits from HRA, Parexel, Recordati, Pfizer, and Sanofi. W.A. and L.P. are employees of Pfizer.